245 related articles for article (PubMed ID: 24790135)
1. Toxic shock syndrome surveillance in UK children.
Adalat S; Dawson T; Hackett SJ; Clark JE;
Arch Dis Child; 2014 Dec; 99(12):1078-82. PubMed ID: 24790135
[TBL] [Abstract][Full Text] [Related]
2. Toxic shock syndrome in Australian children.
Chen KY; Cheung M; Burgner DP; Curtis N
Arch Dis Child; 2016 Aug; 101(8):736-40. PubMed ID: 27117838
[TBL] [Abstract][Full Text] [Related]
3. Toxic shock syndrome in children: epidemiology, pathogenesis, and management.
Chuang YY; Huang YC; Lin TY
Paediatr Drugs; 2005; 7(1):11-25. PubMed ID: 15777108
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and Clinical Relevance of Toxic Shock Syndrome in US Children.
Gaensbauer JT; Birkholz M; Smit MA; Garcia R; Todd JK
Pediatr Infect Dis J; 2018 Dec; 37(12):1223-1226. PubMed ID: 29601458
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections.
Carapetis JR; Jacoby P; Carville K; Ang SJ; Curtis N; Andrews R
Clin Infect Dis; 2014 Aug; 59(3):358-65. PubMed ID: 24785239
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Molecular Epidemiology of Staphylococcal Toxic Shock Syndrome in the United Kingdom.
Sharma H; Smith D; Turner CE; Game L; Pichon B; Hope R; Hill R; Kearns A; Sriskandan S
Emerg Infect Dis; 2018 Feb; 24(2):258-66. PubMed ID: 29350159
[TBL] [Abstract][Full Text] [Related]
7. Manifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010-2017
Cook A; Janse S; Watson JR; Erdem G
Emerg Infect Dis; 2020 Jun; 26(6):1077-1083. PubMed ID: 32442091
[TBL] [Abstract][Full Text] [Related]
8. Similarities and Differences Between Staphylococcal and Streptococcal Toxic Shock Syndromes in Children: Results From a 30-Case Cohort.
Javouhey E; Bolze PA; Jamen C; Lina G; Badiou C; Poyart C; Portefaix A; Tristan A; Laurent F; Bes M; Vandenesch F; Gilletand Y; Dauwalder O
Front Pediatr; 2018; 6():360. PubMed ID: 30547021
[No Abstract] [Full Text] [Related]
9. Managing toxic shock syndrome with antibiotics.
Annane D; Clair B; Salomon J
Expert Opin Pharmacother; 2004 Aug; 5(8):1701-10. PubMed ID: 15264985
[TBL] [Abstract][Full Text] [Related]
10. Toxic shock syndrome: major advances in pathogenesis, but not treatment.
Low DE
Crit Care Clin; 2013 Jul; 29(3):651-75. PubMed ID: 23830657
[TBL] [Abstract][Full Text] [Related]
11. Streptococcal toxic shock syndrome: a description of 14 cases from North Yorkshire, UK.
Barnham MR; Weightman NC; Anderson AW; Tanna A
Clin Microbiol Infect; 2002 Mar; 8(3):174-81. PubMed ID: 12010172
[TBL] [Abstract][Full Text] [Related]
12. [Toxic shock syndrome in 8 children].
Hazelzet JA; Oudshoorn JH; van der Voort EE
Ned Tijdschr Geneeskd; 1994 Oct; 138(40):2001-4. PubMed ID: 7935957
[TBL] [Abstract][Full Text] [Related]
13. Invasive Group A streptococcal disease in Ireland, 2004 to 2010.
Martin J; Murchan S; O'Flanagan D; Fitzpatrick F
Euro Surveill; 2011 Oct; 16(41):. PubMed ID: 22008200
[TBL] [Abstract][Full Text] [Related]
14. Toxic shock syndrome. Are you recognizing its changing presentations?
Strausbaugh LJ
Postgrad Med; 1993 Nov; 94(6):107-8, 111-3, 117-8. PubMed ID: 8234093
[TBL] [Abstract][Full Text] [Related]
15. Clindamycin in the treatment of streptococcal and staphylococcal toxic shock syndromes.
Russell NE; Pachorek RE
Ann Pharmacother; 2000; 34(7-8):936-9. PubMed ID: 10928407
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.
Shah SS; Hall M; Srivastava R; Subramony A; Levin JE
Clin Infect Dis; 2009 Nov; 49(9):1369-76. PubMed ID: 19788359
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics.
DeVries AS; Lesher L; Schlievert PM; Rogers T; Villaume LG; Danila R; Lynfield R
PLoS One; 2011; 6(8):e22997. PubMed ID: 21860665
[TBL] [Abstract][Full Text] [Related]
18. Gram-positive toxic shock syndromes.
Lappin E; Ferguson AJ
Lancet Infect Dis; 2009 May; 9(5):281-90. PubMed ID: 19393958
[TBL] [Abstract][Full Text] [Related]
19. [Toxic shock syndrome].
Tyll T; Bílková M; Revinová A; Müller M; Čurdová M; Zlámal M; Holub M
Epidemiol Mikrobiol Imunol; 2015 Oct; 64(4):210-20. PubMed ID: 26795225
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group.
Kaul R; McGeer A; Norrby-Teglund A; Kotb M; Schwartz B; O'Rourke K; Talbot J; Low DE
Clin Infect Dis; 1999 Apr; 28(4):800-7. PubMed ID: 10825042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
